Skip to content
M

Matthew Babalola

Publications (4)

The Role of Minocycline in Alzheimer’s Disease: Acetylcholinesterase Inhibition and Neuroprotective Mechanisms

Faith Omosigho, Matthew Babalola, Fatimoh Ikeoluwa Egbinola, Ogbonna Kosisochukwu Doris, Kernen Paul Agwaza, Ewaoluwa Promise Owoyemi, Sushma Bhuvanagiri & James Michael Ugochukwu · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2025

Minocycline, a semisynthetic tetracycline antibiotic, has garnered attention for its potential therapeutic effects on Alzheimer’s disease (AD). It has been extensively studied for its potential neuroprotective effects beyond its antimicrobial properties. This review explores the...

Open access Research Article 10.9734/ajrimps/2025/v14i1298

Antimicrobial Resistance in MRSA: A One Health Perspective on Animal, Plant, and Microbial Interactions

Faridah Mobolanle Banwo, Daniel Ossai, Matthew Babalola, Aishatu Muhammad Malami, Chinwe Justice-Alucho, Chinonso Gerald Udensi, Ezinne Tiffany George, Sandra Chibuzor Olisakwe & Jonathan Gebechukwu Areji · Microbiology Research Journal International · 2026

Methicillin-resistant Staphylococcus aureus (MRSA) is no longer simply a hospital problem; it has spread to communities, animals, and the environment, posing a significant public health risk. Its capacity to resist common antibiotics stems from the acquisition of resistance genes...

Open access Research Article 10.9734/mrji/2026/v36i31717

Genomic Evolution and Dynamics of Drug Resistance in Mycobacterium Tuberculosis across West Africa- A Review

Oluwabusola Oluwakorede Asenuga, James Ponman Sargwak, Emmanuel Chimeh Ezeako, Matthew Babalola, Faith Omosigho, Eberechukwu Osinachi Azubuike & Chibuzo Valentine Nwokafor · Microbiology Research Journal International · 2024

Background: The continuous evolution of drug-resistant Tuberculosis strains around the globe, particularly in West Africa, continues to be a major public health problem and poses serious threats to the actualization of the ”End Tuberculosis Strategy” projected by 2030. Hence, a c...

Open access Research Article 10.9734/mrji/2024/v34i111504

Pyocin as an Alternative for Antibiotic Resistance

Zichat Blessing Kuyet, Ahmed Akorede Zakarriyah, Adaobi Fiona Nwokeji, Faith Omosigho, Matthew Babalola, Fatimoh Ikeoluwa Egbinola, Miriam Amarachi Mike, Kelechi Emmanuel Amanze & Goodluck Chibunna Ogboenyie · International Journal of Pathogen Research · 2025

Antimicrobial resistance (AMR) poses a major threat to health worldwide. Undermining decades of progress in medical science, pyocin, a bacteriocin synthesized by Pseudomonas aeruginosa, has caught the attention of academics as a viable alternative to conventional antibiotics. In...

Open access Research Article 10.9734/ijpr/2025/v14i2350